Dr. Reddy's Laboratories Ltd. (RDY)
11.55
-0.36
(-3.02%)
USD |
NYSE |
Sep 15, 16:00
11.54
-0.01
(-0.09%)
Pre-Market: 20:00
Dr. Reddy's Laboratories Price : 11.55 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 11.80 | 11.82 | 11.51 | 11.55 | 4.228M |
| Sep 14, 2026 | 11.93 | 11.94 | 11.86 | 11.91 | 2.409M |
| Sep 11, 2026 | 11.92 | 12.03 | 11.89 | 11.90 | 3.144M |
| Sep 10, 2026 | 11.86 | 11.86 | 11.67 | 11.71 | 2.931M |
| Sep 09, 2026 | 11.87 | 11.97 | 11.82 | 11.88 | 3.502M |
| Sep 08, 2026 | 11.78 | 11.90 | 11.69 | 11.88 | 2.135M |
| Sep 04, 2026 | 12.01 | 12.06 | 11.90 | 11.97 | 2.344M |
| Sep 03, 2026 | 12.05 | 12.17 | 11.92 | 12.03 | 5.505M |
| Sep 02, 2026 | 12.12 | 12.20 | 12.12 | 12.17 | 4.010M |
| Sep 01, 2026 | 12.21 | 12.28 | 12.15 | 12.17 | 1.932M |
| Aug 31, 2026 | 12.01 | 12.22 | 12.01 | 12.13 | 2.160M |
| Aug 28, 2026 | 12.33 | 12.33 | 12.12 | 12.18 | 1.674M |
| Aug 27, 2026 | 12.18 | 12.24 | 12.13 | 12.16 | 1.551M |
| Aug 26, 2026 | 12.25 | 12.30 | 12.14 | 12.22 | 1.675M |
| Aug 25, 2026 | 12.28 | 12.38 | 12.22 | 12.34 | 1.770M |
| Aug 24, 2026 | 12.24 | 12.25 | 12.13 | 12.22 | 2.070M |
| Aug 21, 2026 | 12.13 | 12.22 | 12.06 | 12.18 | 2.021M |
| Aug 20, 2026 | 12.12 | 12.23 | 12.05 | 12.11 | 2.552M |
| Aug 19, 2026 | 12.17 | 12.22 | 11.99 | 12.11 | 3.263M |
| Aug 18, 2026 | 12.12 | 12.21 | 12.06 | 12.15 | 3.069M |
| Aug 17, 2026 | 12.20 | 12.24 | 12.06 | 12.11 | 2.043M |
| Aug 14, 2026 | 12.33 | 12.38 | 12.22 | 12.27 | 2.263M |
| Aug 13, 2026 | 12.43 | 12.51 | 12.37 | 12.42 | 2.803M |
| Aug 12, 2026 | 12.34 | 12.42 | 12.32 | 12.39 | 2.218M |
| Aug 11, 2026 | 12.55 | 12.58 | 12.42 | 12.45 | 2.372M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Teva Pharmaceutical Industries Ltd. | 39.25 |
| Takeda Pharmaceutical Co., Ltd. | 18.70 |
| Novo Nordisk A/S | 42.53 |
| Perrigo Co. Plc | 13.56 |
| Innoviva, Inc. | 20.84 |
Price Related Metrics
| PE Ratio | 25.96 |
| PS Ratio | 2.631 |
| Price to Book Value | 2.375 |
| Price to Free Cash Flow | 126.59 |
| Earnings Yield | 3.85% |
| Market Cap | 9.621B |
| Operating PE Ratio | 26.12 |